Last reviewed · How we verify
NCT04619108
Thrombosomes for Expanded Access Use
trial testing Thrombosomes® in Bleeding. No longer available.
Quick facts
| Lead sponsor | Cellphire Therapeutics, Inc. |
|---|---|
| Status | NO LONGER AVAILABLE |
| Study type | EXPANDED_ACCESS |
Drugs / interventions tested
- Thrombosomes® — full drug profile →
Conditions studied
- Bleeding — all drugs for Bleeding →
Sponsor
Cellphire Therapeutics, Inc. — full company profile →
Who can join
18 and older, any sex, with Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Expanded use of Thrombosomes where a clinical trial with Thrombosomes is not an option, Cellphire may elect to provide the Sponsor/Investigator (S/I) expanded access to its investigational product, Thrombosomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lyophilized platelets inhibit platelet aggregation with simultaneous paradoxical promotion of platelet adhesion.
Schnoor B, Papa AL. · · 2022 · cited 5× · PMID 36061448 · DOI 10.3389/fbioe.2022.941817
Verify or expand the search:
- PubMed search for NCT04619108
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Thrombosomes®
Trials testing the same drug.
- NCT05771831 — Thrombosomes® in Acute Thoracic Aortic Dissections · Phase 2 · completed
Other recruiting trials for Bleeding
Currently open trials in the same condition.
- NCT07401394 — BAR-TAX - Tranexamic Acid in Bariatric Surgery. · NA · active not recruiting
- NCT07309848 — Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs · recruiting
- NCT07083583 — Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders · recruiting
- NCT07019077 — Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagu · recruiting
- NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting
Other Cellphire Therapeutics, Inc. trials
Trials by the same sponsor.
- NCT04709705 — DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) · Phase 2, PHASE3 · completed
- NCT04631211 — Thrombosomes® in Bleeding Thrombocytopenic Patients Study · Phase 2 · terminated
- NCT03394755 — Thrombosomes® in Bleeding Thrombocytopenic Patients · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04619108 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cellphire Therapeutics, Inc.
- Last refreshed: 21 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04619108.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing